{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Art+Therapy&page=5", "query": { "condition": "Art Therapy", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 567, "total_pages": 57, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Art+Therapy&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Art+Therapy&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T01:26:30.112Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00414518", "title": "Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Tenofovir disoproxil fumarate/Emtricitabine", "type": "DRUG" }, { "name": "Lopinavir/Ritonavir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2007-01", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2013-02-20", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 2, "location_summary": "Denver, Colorado • Atlanta, Georgia", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00414518" }, { "nct_id": "NCT00917813", "title": "A Study of Anti-HIV Monoclonal Antibody KD-247", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "KD-247", "type": "DRUG" }, { "name": "Physiological saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Chemo-Sero-Therapeutic Research Institute", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 27, "start_date": "2007-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-11-19", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 15, "location_summary": "Beverly Hills, California • Burbank, California • Los Angeles, California + 12 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00917813" }, { "nct_id": "NCT03538899", "title": "Autologous Gene Therapy for Artemis-Deficient SCID", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Severe Combined Immunodeficiency" ], "interventions": [ { "name": "AProArt-CD34", "type": "DRUG" }, { "name": "CliniMACS® CD34 Reagent System cell sorter device", "type": "DEVICE" }, { "name": "Busulfan", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": null, "sex": "ALL", "summary": "2 Months and older" }, "enrollment_count": 24, "start_date": "2018-05-31", "completion_date": "2038-06", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03538899" }, { "nct_id": "NCT04493034", "title": "Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Art Therapy", "type": "BEHAVIORAL" }, { "name": "Music Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 73, "start_date": "2021-04-21", "completion_date": "2024-01-22", "has_results": false, "last_update_posted_date": "2024-12-18", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 1, "location_summary": "Weston, Florida", "locations": [ { "city": "Weston", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04493034" }, { "nct_id": "NCT00454181", "title": "Treatment of Oral Warts in HIV+ Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Papillomatosis", "HIV Infections" ], "interventions": [ { "name": "Interferon-alpha", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Ainos, Inc. (f/k/a Amarillo Biosciences Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2007-02", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2011-09-16", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 12, "location_summary": "San Francisco, California • Fort Lauderdale, Florida • Augusta, Georgia + 9 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00454181" }, { "nct_id": "NCT04985760", "title": "Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant", "type": "BIOLOGICAL" }, { "name": "Placebo control for Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant", "type": "BIOLOGICAL" }, { "name": "Trimer 4571 vaccine 500mcg with 500mcg alum adjuvant", "type": "BIOLOGICAL" }, { "name": "Placebo control for Trimer 4571 vaccine 500mcg with 500mcg alum adjuvant", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Madhu Chhanda Choudhary", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2021-09-30", "completion_date": "2026-01-16", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 2, "location_summary": "Columbus, Ohio • Pittsburgh, Pennsylvania", "locations": [ { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04985760" }, { "nct_id": "NCT05540106", "title": "Impact of Art Therapy on Self-Reported Pain and Anxiety Scores of Patients Waiting to Be Seen in the Emergency Department", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety", "Pain" ], "interventions": [ { "name": "Nature Coloring Packet", "type": "BEHAVIORAL" }, { "name": "Geometric Shape Coloring Packet", "type": "BEHAVIORAL" }, { "name": "Activity Book", "type": "BEHAVIORAL" }, { "name": "Blank Paper and Pencil", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stony Brook University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 168, "start_date": "2023-08-01", "completion_date": "2027-12-01", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 1, "location_summary": "Stony Brook, New York", "locations": [ { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05540106" }, { "nct_id": "NCT03819114", "title": "Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections", "Tuberculosis" ], "interventions": [ { "name": "Levonorgestrel (LNG)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "FEMALE", "summary": "16 Years and older · Female only" }, "enrollment_count": 122, "start_date": "2019-05-06", "completion_date": "2020-11-30", "has_results": true, "last_update_posted_date": "2021-12-27", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 7, "location_summary": "Chicago, Illinois • New York, New York • Chapel Hill, North Carolina + 3 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03819114" }, { "nct_id": "NCT02405026", "title": "Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma", "HIV" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2014-12", "completion_date": "2017-07", "has_results": false, "last_update_posted_date": "2017-10-03", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02405026" }, { "nct_id": "NCT00001119", "title": "Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Tetanus Toxoid Vaccine", "type": "BIOLOGICAL" }, { "name": "Indinavir sulfate", "type": "DRUG" }, { "name": "Lamivudine/Zidovudine", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Abacavir sulfate", "type": "DRUG" }, { "name": "Amprenavir", "type": "DRUG" }, { "name": "Efavirenz", "type": "DRUG" }, { "name": "Hepatitis B Vaccine (Recombinant)", "type": "BIOLOGICAL" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 288, "start_date": "1999-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2011-03-02", "last_synced_at": "2026-10-03T01:26:30.112Z", "location_count": 11, "location_summary": "San Francisco, California • Chicago, Illinois • Boston, Massachusetts + 6 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001119" } ] }